AU2014267349A1 - Agent and method for treating herpes - Google Patents

Agent and method for treating herpes Download PDF

Info

Publication number
AU2014267349A1
AU2014267349A1 AU2014267349A AU2014267349A AU2014267349A1 AU 2014267349 A1 AU2014267349 A1 AU 2014267349A1 AU 2014267349 A AU2014267349 A AU 2014267349A AU 2014267349 A AU2014267349 A AU 2014267349A AU 2014267349 A1 AU2014267349 A1 AU 2014267349A1
Authority
AU
Australia
Prior art keywords
composition
herpes
use according
methylpropanol
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014267349A
Other languages
English (en)
Inventor
Nadine Heiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Najopharm GmbH
Original Assignee
Najopharm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Najopharm GmbH filed Critical Najopharm GmbH
Publication of AU2014267349A1 publication Critical patent/AU2014267349A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2014267349A 2013-05-14 2014-05-14 Agent and method for treating herpes Abandoned AU2014267349A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13167597.7A EP2803354B1 (de) 2013-05-14 2013-05-14 Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
EP13167597.7 2013-05-14
PCT/EP2014/059813 WO2014184223A1 (de) 2013-05-14 2014-05-14 Mittel und verfahren zur behandlung von herpes

Publications (1)

Publication Number Publication Date
AU2014267349A1 true AU2014267349A1 (en) 2015-12-03

Family

ID=48366229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014267349A Abandoned AU2014267349A1 (en) 2013-05-14 2014-05-14 Agent and method for treating herpes

Country Status (7)

Country Link
US (1) US20160166603A1 (cg-RX-API-DMAC10.html)
EP (1) EP2803354B1 (cg-RX-API-DMAC10.html)
JP (1) JP2016518424A (cg-RX-API-DMAC10.html)
AU (1) AU2014267349A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015028334A2 (cg-RX-API-DMAC10.html)
ES (1) ES2538335T3 (cg-RX-API-DMAC10.html)
WO (1) WO2014184223A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
DE102025101480A1 (de) 2025-01-16 2026-07-16 Pigmentsolution GmbH Konservierungszusammensetzung
DE202026100173U1 (de) 2025-01-16 2026-05-28 Pigmentsolution GmbH Rohr-im-Rohr-Homogenisierer
EP4778390A3 (de) 2025-01-16 2026-08-12 Pigmentsolution GmbH Konservierungszusammensetzung

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2174242A (en) 1937-08-13 1939-09-26 Purdue Research Foundation Aminoglycols
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPS62263111A (ja) * 1986-05-09 1987-11-16 Shiseido Co Ltd 粘性組成物
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5622690A (en) * 1990-04-05 1997-04-22 Nurture, Inc. Seed-derived proteinaceous compositions for reduction of sunburn cell formation
JPH08143460A (ja) * 1994-11-17 1996-06-04 Haruhito Miyata 水虫類の治療方法及び用材
JPH11511180A (ja) * 1996-06-12 1999-09-28 ストア ソシエテ アノニマ 化粧品のための物理的殺菌用ゲル
US7442369B1 (en) * 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
JPWO2004069261A1 (ja) * 2003-02-03 2006-05-25 アリジェン株式会社 抗ヘルペスウイルス外用製剤の製造方法
JP2005263695A (ja) * 2004-03-18 2005-09-29 Suiko Giken Kk 水虫治療薬
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
US8267927B2 (en) * 2007-01-24 2012-09-18 Koninklijke Philips Electronics N.V. Advanced ablation planning
WO2010127033A1 (en) * 2009-04-28 2010-11-04 Alltranz Inc. Formulations of cannabidiol and methods of using the same
IT1395137B1 (it) * 2009-08-05 2012-09-05 Spider Biotech S R L Nuovi peptidi antipatogeni
JP2011030981A (ja) * 2009-08-06 2011-02-17 Dainippon Printing Co Ltd 皮膚貼付用組成物および皮膚貼付用材
WO2012004669A1 (en) * 2010-07-08 2012-01-12 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US20130072575A1 (en) * 2011-09-19 2013-03-21 Johnson & Johnson Consumer Companies, Inc. Method and Composition for Treating Pain

Also Published As

Publication number Publication date
BR112015028334A2 (pt) 2017-07-25
EP2803354A1 (de) 2014-11-19
JP2016518424A (ja) 2016-06-23
WO2014184223A1 (de) 2014-11-20
ES2538335T3 (es) 2015-06-19
EP2803354B1 (de) 2015-03-04
US20160166603A1 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
US9387227B2 (en) Method for treatment of sores and lesions of the skin
US20160166603A1 (en) Agent and method for treating herpes
US5744167A (en) Methods for the treatment of herpes virus infections
US20090220440A1 (en) Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections
van der Spuy, S., Levy, DW & Levin Cimetidine in the treatment of herpesvirus infections
US20140011838A1 (en) Compositions and methods for treating warts associated with viral infections
EP3294267A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
JP2954366B2 (ja) 活性成分としてクロラムフェニコール、ゲンタマイシンおよびナイスタチンを含有する、炎症性皮膚疾患の局所治療のための配合製剤
ES2880437T3 (es) Nuevas composiciones tópicas que comprenden ácido úsnico y su uso terapéutico
US20170020946A1 (en) Analgesic compositions and methods of use
US20140011837A1 (en) Compositions and methods for treating warts associated with viral infections
KR20080053319A (ko) 브리부딘을 함유하는 헤르페스 각막염 치료용 광안정 약학조성물
CN106413699B (zh) 外用药物组合物
CN100558363C (zh) 一种治疗尖锐湿疣的药物组合物
JP7156825B2 (ja) 外用医薬組成物
WO2019072353A1 (en) TOPICAL PHARMACEUTICAL PREPARATION OF BETAMETHASONE, CALCIPOTRIOL AND ROSE OIL FOR THE TREATMENT OF PSORIASIS
JP7229678B2 (ja) 外用医薬組成物
EP4731182A1 (en) Topical regimen for treating cold sores
RU2147440C1 (ru) Обезболивающее и противозудное средство
HK1229693B (en) Pharmaceutical composition for external use
CH715156A2 (it) Composizione per il trattamento di una lesione erpetica nascente
HK1228740B (en) Pharmaceutical composition for external use
HU224882B1 (hu) Fájdalomcsillapító, gyulladásgátló és izomlazító kenõcs
HK1229216B (en) Pharmaceutical composition for external use
HK1094756A (en) Method for treatment of sores and lesions of the skin

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application